Avinger, Inc. (AVGR)

Market Cap	3.90M
Revenue (ttm)	7.75M
Net Income (ttm)	-18.61M
Shares Out	1.28M
EPS (ttm)	-31.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,967
Open	3.03
Previous Close	3.07
Day's Range	3.03 - 3.24
52-Week Range	2.78 - 24.30
Beta	1.29
Analysts	Strong Buy
Price Target	5.00 (+62.34%)
Earnings Date	Oct 26, 2023

About AVGR

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as wel...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Jan 30, 2015
• Employees: 71
• Stock Exchange: NASDAQ
• Ticker Symbol: AVGR

Financial Performance

In 2022, Avinger's revenue was $8.27 million, a decrease of -18.33% compared to the previous year's $10.13 million. Losses were -$27.24 million, 26.2% more than in 2021.

Analyst Forecast

According to one analyst, the rating for AVGR stock is "Strong Buy" and the 12-month stock price forecast is $5.0.

Price Target

$5.0

(62.34% upside)

Analyst Consensus: Strong Buy